You can learn about a more comprehensive Argo Biopharma through the latest information.
Argo Biopharma’s first siRNA drug approved for clinical study in Australia.
Argo Biopharma closed series A financing of 63 million US dollars.
Argo Biopharma closed angel round financing of nearly 5 millon US dollars.
为了更好的呈现效果,移动端请竖屏浏览